Atossa Therapeutics (ATOS) Current Assets (2011 - 2026)
Atossa Therapeutics (ATOS) posted Current Assets of $31.01 million for Q2 2026, down 50.4% from $62.52 million a year earlier and down 15.4% from the prior quarter.
Atossa Therapeutics (ATOS) Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Atossa Therapeutics' Current Assets came in at $45.62 million, down 38.7% from FY2024.
- Annual Current Assets has declined for four consecutive years, though with a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- In prior years, Atossa Therapeutics' Current Assets was $74.46 million in FY2024 (-19.3%), $92.22 million in FY2023 (-22.0%), $118.2 million in FY2022 (-16.3%) and $141.24 million in FY2021 (+230.2%).
- The Q2 2026 figure stands as the lowest quarterly Current Assets since Q3 2020.
- On a year-over-year basis, Current Assets has declined in each of the last 18 quarters, with an average decline of 31.1% over the last eight quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was Q4 2021, with growth of 230.2%; the weakest was Q2 2026, with a decline of 50.4%.
- According to Business Quant data, Current Assets for the three prior quarters was $36.67 million (Q1 2026), $45.62 million (Q4 2025) and $55.68 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Atossa Therapeutics | 19.96 Mn | -131.01 Mn | - | 31.01 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.01 Mn |
| Mar 31, 2026 | 36.67 Mn |
| Dec 31, 2025 | 45.62 Mn |
| Sep 30, 2025 | 55.68 Mn |
| Jun 30, 2025 | 62.52 Mn |
| Mar 31, 2025 | 68.74 Mn |
| Dec 31, 2024 | 74.46 Mn |
| Sep 30, 2024 | 77.11 Mn |
| Jun 30, 2024 | 81.72 Mn |
| Mar 31, 2024 | 87.06 Mn |
| Dec 31, 2023 | 92.22 Mn |
| Sep 30, 2023 | 97.65 Mn |
| Jun 30, 2023 | 106.00 Mn |
| Mar 31, 2023 | 110.87 Mn |
| Dec 31, 2022 | 118.20 Mn |
| Sep 30, 2022 | 123.40 Mn |
| Jun 30, 2022 | 133.42 Mn |
| Mar 31, 2022 | 136.85 Mn |
| Dec 31, 2021 | 141.24 Mn |
| Sep 30, 2021 | 142.99 Mn |
Atossa Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ATOS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();